A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer

NCT00550173 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small-Cell Lung Cancer

Interventions

DRUG: pemetrexed
DRUG: erlotinib

Sponsor

Eli Lilly and Company